These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 8676822

  • 21. Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition.
    Hughes TA, Gaber AO, Amiri HS, Wang X, Elmer DS, Winsett RP, Hathaway DK, Hughes SM.
    Transplantation; 1995 Dec 27; 60(12):1406-12. PubMed ID: 8545865
    [Abstract] [Full Text] [Related]

  • 22. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.
    Gynecol Endocrinol; 2005 May 27; 20(5):258-63. PubMed ID: 16019370
    [Abstract] [Full Text] [Related]

  • 23. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM, Knight-Gibson C, Samuelsson O, Attman PO, Wang CS, Alaupovic P.
    Kidney Int; 2002 Jan 27; 61(1):209-18. PubMed ID: 11786103
    [Abstract] [Full Text] [Related]

  • 24. [Therapy of hyperlipoproteinemia].
    Drexel H, Follath F.
    Schweiz Rundsch Med Prax; 1993 Apr 27; 82(17):506-9. PubMed ID: 8493437
    [Abstract] [Full Text] [Related]

  • 25. Lipoprotein abnormalities in adult nephrotic syndrome.
    Ongajyooth L, Sirisalee K, Laohaphand T, Parichatiganond P, Shayakul C, Nilwarangkur S.
    J Med Assoc Thai; 1993 Sep 27; 76(9):512-20. PubMed ID: 7964258
    [Abstract] [Full Text] [Related]

  • 26. Measurement of cholesterol concentrations of major serum lipoprotein classes in haemodialysis patients by anion-exchange chromatography.
    Hirowatari Y, Yoshida H, Fueki Y, Ito M, Ogura Y, Sakurai N, Miida T.
    Ann Clin Biochem; 2008 Nov 27; 45(Pt 6):571-4. PubMed ID: 18782818
    [Abstract] [Full Text] [Related]

  • 27. Unusual dyslipoproteinemia in a patient with primary systemic amyloidosis and nephrotic syndrome. Role of excessive cholesterol synthesis.
    Eisenberg S, Oschry Y, Schattner A, Bentwich Z.
    Isr J Med Sci; 1984 Mar 27; 20(3):224-31. PubMed ID: 6724868
    [Abstract] [Full Text] [Related]

  • 28. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD, Stroes ES, Willekes-Koolschijn N, Rabelink TJ, Koomans HA, Joles JA.
    Kidney Int; 1999 Mar 27; 55(3):1005-10. PubMed ID: 10027937
    [Abstract] [Full Text] [Related]

  • 29. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
    Prata MM, Nogueira AC, Pinto JR, Correia AM, Vicente O, Rodrigues MC, Miguel MJ.
    Clin Nephrol; 1994 May 27; 41(5):277-83. PubMed ID: 8050207
    [Abstract] [Full Text] [Related]

  • 30. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G, Ozben T, Sapan M, Yìlmaz H, Yakupoglu G, Karpuzoglu T.
    Transplant Proc; 1994 Oct 27; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract] [Full Text] [Related]

  • 31. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND.
    Kidney Int; 2016 Jul 27; 90(1):41-52. PubMed ID: 27165836
    [Abstract] [Full Text] [Related]

  • 32. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG, Kaysen GA, Barrett HA, Stellaard F, Gadellaa MM, Voorbij HA, Reijngoud DJ, Rabelink TJ.
    Kidney Int; 1998 Apr 27; 53(4):994-1001. PubMed ID: 9551409
    [Abstract] [Full Text] [Related]

  • 33. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN, Tvorogova MG, Levitova EN, Krylova EA.
    Vopr Med Khim; 1983 Apr 27; 29(2):17-23. PubMed ID: 6858031
    [Abstract] [Full Text] [Related]

  • 34. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
    Stenvinkel P, Berglund L, Ericsson S, Alvestrand A, Angelin B, Eriksson M.
    Eur J Clin Invest; 1997 Feb 27; 27(2):169-77. PubMed ID: 9061312
    [Abstract] [Full Text] [Related]

  • 35. Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome.
    Toto RD, Grundy SM, Vega GL.
    Am J Nephrol; 2000 Feb 27; 20(1):12-7. PubMed ID: 10644862
    [Abstract] [Full Text] [Related]

  • 36. Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Ong-Ajyooth L, Sirisalee K, Shayakul C, Vareesangthip K, Vasuvattakul S, Vanichakarn S, Nimmannit S, Chirawong P, Ong-Ajyooth S, Nilwarangkur S.
    Transplant Proc; 1994 Aug 27; 26(4):2077-9. PubMed ID: 8066677
    [No Abstract] [Full Text] [Related]

  • 37. VLDL and LDL metabolism in human and rat mesangial cells.
    Krämer-Guth A, Nauck M, Quaschning T, Pavenstädt H, Wieland H, Schollmeyer P, Wanner C.
    Nephron; 1996 Aug 27; 74(2):378-85. PubMed ID: 8893159
    [Abstract] [Full Text] [Related]

  • 38. Growth, serum lipoproteins and apoproteins in infants with congenital nephrosis.
    Antikainen M, Holmberg C, Taskinen MR.
    Clin Nephrol; 1992 Nov 27; 38(5):254-63. PubMed ID: 1451338
    [Abstract] [Full Text] [Related]

  • 39. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure.
    Joven J, Rubiés-Prat J, Espinel E, Ras MR, Piera L.
    Nephrol Dial Transplant; 1987 Nov 27; 2(3):149-53. PubMed ID: 3114674
    [Abstract] [Full Text] [Related]

  • 40. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes.
    Simonen PP, Gylling H, Miettinen TA.
    Atherosclerosis; 2007 Sep 27; 194(1):222-9. PubMed ID: 16963050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.